Anxiety Disorders in Neurologic Illness.

Area of Science:

• Neurology
• Psychiatry
• Clinical Psychology

Background:

• Anxiety disorders frequently co-occur with neurologic illnesses, presenting as symptoms, reactions, side effects, or comorbidities.
• Common anxiety disorders in neurologic patients include panic disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder (OCD).
• Untreated anxiety can significantly increase morbidity and mortality in individuals with neurologic conditions.

Purpose of the Study:

• To review the prevalence and treatment of anxiety disorders in patients with neurologic illness.
• To highlight the importance of recognizing and treating anxiety in this population.
• To discuss pharmacologic and non-pharmacologic treatment options.

Main Methods:

• Literature review of anxiety disorders in neurologic populations.
• Discussion of common anxiety disorder presentations and their impact.
• Evaluation of treatment efficacy for selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, and cognitive behavioral therapy (CBT).

Main Results:

• Selective serotonin reuptake inhibitors (SSRIs) are recommended as first-line pharmacologic treatment due to broad efficacy and tolerability, also addressing comorbid depression.
• Benzodiazepines are effective for acute anxiety but are considered second-line or adjunctive treatments.
• Cognitive behavioral therapy (CBT) and other behavioral interventions are effective primary treatments, especially for patients who cannot or prefer not to use medication.

Conclusions:

• Anxiety disorders are a significant concern in neurologic illness, requiring recognition and treatment.
• SSRIs are the preferred first-line pharmacologic treatment for anxiety disorders in neurologic patients.
• Behavioral therapies, such as CBT, serve as effective primary treatments and alternatives to medication.